Candorado Signs Agreement to Buy Property Near Eldor Rare Earth Element Property

Candorado Operating Company Ltd. (TSX VENTURE:CDO) (FRANKFURT:HQU) (BERLIN:HQU) has announced today, subject to TSX Venture Exchange approval, that it has entered into an agreement with a private vendor to earn a 100% interest in property located adjacent to Commerce Resources Corp.'s Eldor rare earth element project in Quebec.

Candorado can earn a 100% interest by way of making a one-time payment of $20,000 upon the Exchange's approval, issuing 3,000,000 common shares of the Company within 5 days of approval from the Exchange and is subject to a 2% net smelter return ("NSR"). The NSR may be reduced to 1% at the Company's discretion for $1,000,000.

The acquired ground totals approximately 920 hectares and adjoins Commerce's Eldor Property to the northwest. Commerce announced on November 24, 2010 the latest results from its drill program on the Ashram REE zone, which confirmed the potential for a large, near surface deposit of REE mineralization within the northern parts of the mineralized system.

The acquired ground has identified cerium, yttrium and lanthanum anomalous areas. These anomalous areas were identified by Géologie Québec during the 2010 field season.

Mr. Kirk Reed, President of the Company states: "We are very excited to have acquired additional ground to expand our interests in the province of Quebec. We look forward to following up on the completion of our phase 1 exploration program in the Val d'Or region in June 2010, which confirmed the presence of lithium-bearing pegmatites in surface rock sampling, with the commencement of a second phase exploration drill

Source:

Candorado Operating Company Ltd.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.